Organigram Invests $3M in Phylos for Exclusive Next-Gen Cannabis Genetics, Fuels Global Brand Innovations
Organigram Invests $3M in Phylos for Exclusive Next-Gen Cannabis Genetics, Fuels Global Brand Innovations Organigram Global Inc. made a significant strategic move. Consequently, it announced an expanded investment. The company infused $3 million into Phylos Bioscience. This capital infusion accelerates Organigram’s innovation strategy. As a result, it strengthens their position in the global cannabis market….

